Skip to main content
Log in

The clinical evaluation of silent adrenal masses

  • Review Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Lewinsky B.S., Grigor K.M., Symington T., Neville A.M. The clinical and pathologic feature of “non-hormonal” adrenocortical tumors. Report of twenty new cases and review of the literature. Cancer 33: 778, 1974.

    PubMed  CAS  Google Scholar 

  2. Copeland P.M. The incidentally discovered adrenal mass. Ann. Intern. Med. 95: 940, 1983.

    Google Scholar 

  3. Ross N.S., Aron D.C. Hormonal evaluation of the patient with an incidentally discovered adrenal mass. N. Engl. J. Med. 323: 1401, 1990.

    PubMed  CAS  Google Scholar 

  4. Gross M.D., Shapiro B. Clinically silent adrenal masses. J. Clin. Endocrinol. Metab. 77: 885, 1993.

    PubMed  CAS  Google Scholar 

  5. Belldegrun A., Hussain S., Seltzer S.E., Loughlin K.R., Gittes R.F., Richie J.P. Incidentally discovered mass of the adrenal gland. Surg. Gynecol. Obstet. 163: 203, 1986.

    PubMed  CAS  Google Scholar 

  6. Herrera M.F., Grant C.S., Van Heerden J.A., Sheedy P.F., Ilstrup D.M. Incidentally discovered adrenal tumors: an institutional perspective. Surgery 110: 1014, 1991.

    PubMed  CAS  Google Scholar 

  7. Kloos R.T., Gross M.D., Francis I.R., Korobkin M., Shapiro B. Incidentally discovered adrenal masses. Endocr. Rev. 16: 460, 1995.

    PubMed  CAS  Google Scholar 

  8. Devenyi I. Possibility of normokalaemic primary aldosteronism as reflected in the frequency of adrenal cortical adenomas. J. Clin. Pathol. 20: 49, 1967.

    PubMed Central  PubMed  CAS  Google Scholar 

  9. Russell R.P., Masi A.T., Richter E.D. Adrenal cortical adenomas and hypertension. A clinical pathologic analysis of 690 cases with matched controls and a review of the literature. Medicine (Baltimore) 51: 211, 1972.

    CAS  Google Scholar 

  10. Angeli A., Terzolo M., Osella G., Alì A. Adrenal incidentaloma (I): an overview of clinical and epidemiological data from the National Italian Study Group. 39èmes Journ. Intern. H.-P. Klotz Endocrin. Clin. Paris, 30–31 may 1996, (abs), p. 49, 1996.

  11. Hedeland H., Ostberg G., Hokfelt B. On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Med. Scand. 184: 211, 1968.

    PubMed  CAS  Google Scholar 

  12. Kokko J.P., Brown T.C., Berman M.M. Adrenal adenoma and hypertension. Lancet 1: 468, 1967.

    PubMed  CAS  Google Scholar 

  13. Dobbie J.W. Adrenocortical nodular hyperplasia: the aging adrenal. J. Pathol. 99: 1, 1969.

    PubMed  CAS  Google Scholar 

  14. Granger P., Genest J. Autopsy study of adrenals in unselected normotensive and hypertensive patients. Can. Med. Assoc. J. 103: 34, 1970.

    PubMed Central  PubMed  CAS  Google Scholar 

  15. Neville A.M. The nodular adrenal. Invest. Cell. Pathol. 1: 99, 1978.

    PubMed  CAS  Google Scholar 

  16. Reznek H.R., Armstrong P. Imaging in endocrinology. The adrenal gland. Clin. Endocrinol. 40: 561, 1994.

    CAS  Google Scholar 

  17. Lee M.J., Hahn P.F., Papanicolau N., Egglin T.K., Saini S., Mueller P.R., Simeone J.F. Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 179: 415, 1991.

    PubMed  CAS  Google Scholar 

  18. Reining J.W., Doppman J.L., Dwyer A.J., Johnson A.R., Knop R.H. Adrenal masses differentiated by MR. Radiology 150: 81, 1986.

    Google Scholar 

  19. Chezmar J.L., Robbins S.M., Nelson R.C., Steinberg H.V., Torres W.E., Bernardino M.E. Adrenal masses: characterization with T1 weighted MR imaging. Radiology 166: 357, 1988.

    PubMed  CAS  Google Scholar 

  20. Mitchell D.G., Crovello M., Matteucci T., Petersen R.O., Miettinen M.M. Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology 185: 345, 1992.

    PubMed  CAS  Google Scholar 

  21. Baker M.E., Blinder R., Spritzer C., Leight G.S., Herfkens R.J., Dunnick N.R. MR evaluation of adrenal masses at 1.5 T. Am. J. Roentgenol. 153: 307, 1989.

    CAS  Google Scholar 

  22. van Erkel A.R., van Gils A.P., Lequin M., Kruitwagen C., Bloem J.L., Falke T.H. CT and MR distinction of adenomas and nonadenomas of the adrenal gland. J. Comput. Assist. Tomogr. 18: 432, 1994.

    PubMed  Google Scholar 

  23. Reining W.J., Stutley J.E., Leonhardt C.M., Spicer K.M., Magrolis M., Cadwell C.B. Differentiation of adrenal masses with MR imaging: comparison of techniques. Radiology 192: 41, 1994.

    Google Scholar 

  24. Gross M.D., Shapiro B., Francis I.R., Glazer G.M., Bree R.L., Arcomano M.A., Schteingart D.E., McLeod M.K., Sanfield J.A., Thompson N.W. Scintigraphic evaluation of clinically silent adrenal masses (see comments). J. Nucl. Med. 35: 1145, 1994.

    PubMed  CAS  Google Scholar 

  25. Khafagi F.A., Gross M.D., Shapiro B., Glazer G.M., Francis I., Thompson N.W. Clinical significance of the large adrenal mass. Br. J. Surg. 78: 828, 1991.

    PubMed  CAS  Google Scholar 

  26. Gross M.D., Shapiro B., Francis I.R., Bree R.L., Korobkin M., McLeod M.K., Thompson N.W., Sanfield J.A. Scintigraphy of incidentally discovered bilateral adrenal masses. Eur. J. Nucl. Med. 22: 315, 1995.

    PubMed  CAS  Google Scholar 

  27. Bardet S., Rohmer V., Murat A., Guillemot C., Marechaud R., Chupin M., Lecomte P., Simon D., Delemer B., Schneebelli S., Beutter D., Jacquin V., Peltier P., Charbonnel B. and the West France Study Group on Incidentalomas (WFSGI). 131-I-6β-Iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas. Clin. Endocrinol. (Oxf). 44: 587, 1996.

    CAS  Google Scholar 

  28. Lavoie H., Lacroix A. Partially autonomous Cortisol secretion by incidentally discovered adrenal adenomas. Trends Endocrinol. Metab. 6: 191, 1995.

    PubMed  CAS  Google Scholar 

  29. Chatal T., Charbonnel B. Comparison of iodobenzylguanidine imaging with computed tomography in locating phaeochromocytoma. J. Clin. Endocrinol. Metab. 61: 769, 1985.

    PubMed  CAS  Google Scholar 

  30. Gross M.D., Shapiro B.S. Scintigraphic studies in adrenal hypertension. Semin. Nucl. Med. 19: 122, 1989.

    PubMed  CAS  Google Scholar 

  31. van Gils A.P., Falke T.H., van Erkel A.R., van de Velde C.J., Pauwels E.K. Non-invasive imaging of functioning paragangliomas (including phaeochromocytomas). Front. Eur. Radiol. 7: 1, 1990.

    Google Scholar 

  32. Mantero F., Masini A.M., Opocher G., Giovagnetti M., Amaldi G. Adrenal incidentaloma (2): an overview of hormonal data from the national italian study group. 39èmes Journ. Intern. H.-P. Klotz Endocrin. Clin. Paris, 30–31 May 1996, (abs), p. 51, 1996.

  33. Aso Y., Homma Y. A survey on incidental adrenal tumors in Japan. J. Urol. 147: 1478, 1992.

    PubMed  CAS  Google Scholar 

  34. Hoefnagel C.A. Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours. Eur. J. Nucl. Med. 21: 561, 1994.

    PubMed  CAS  Google Scholar 

  35. Maurea S., Lastoria S., Caraco C., Klain M., Varrella P., Acampa W., Muto P., Salvatore M. The role of radiolabeled somatostatin analogs in adrenal imaging. Nucl. Med. Biol. 23: 677, 1996.

    PubMed  CAS  Google Scholar 

  36. Gross M.D., Falke T.H.M., Shapiro B., Sandler M.P. Adrenal glands. In: Sandler M.P., Patton J.A., Gross M.D., Shapiro B., Falke T.H.M. (Eds.), Endocrine Imagines. Appleton and Lange, Norwalk, Connecticut, 1992, p. 271.

    Google Scholar 

  37. Bernardino M.E., Walther M.M., Phillips V.M., Graham Jr S.D., Sewell C.W., Gedgausas-McCless K., Baumgartner B.R., Torres W.E., Erwin B.C. CT-guided adrenal biopsy: accuracy, safety, and indications. Am. J. Roentgenol. 144: 67, 1985.

    CAS  Google Scholar 

  38. Yankaskas B.C., Staab E.V., Cravem M.B., et al. Delayed complications from fine-needle biopsies of solid masses of the abdomen. Invest. Radiol. 21: 325, 1986.

    PubMed  CAS  Google Scholar 

  39. Oelkers W. Diagnostic puzzle of the adrenal “incidentaloma”. Eur. J. Endocrinol. 132: 419, 1995.

    PubMed  CAS  Google Scholar 

  40. Cook D.M., Loriaux D.L. The incidental adrenal mass. The Endocrinologist 6: 4, 1996.

    Google Scholar 

  41. Hensen J., Buhl M., Bähr V., Oelkers W. Endocrine activity of the “silent” adrenocortical adenoma is uncovered by response to corticotropin-releasing-hormone. Klin. Wochenschr. 68: 608, 1990.

    PubMed  CAS  Google Scholar 

  42. Jockenhovel F., Kuck W., Hauffa B., Reinhardt W., Benker G., Lederbogen S., Olbricht Th., Reinwein D. Consecutive and surgical management of incidentally discovered adrenal tumors (incidentalomas). J. Endocrinol. Invest. 15: 331, 1992.

    PubMed  CAS  Google Scholar 

  43. Flecchia D., Mazza E., Carlini M., Blatto A., Olivieri F., Serra G., Camanni F., Messina M. Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour. Clin. Endocrinol. (Oxf). 42: 129, 1995.

    CAS  Google Scholar 

  44. Reincke M., Nieke J., Krestin G.P., Saeger W., Allolio B., Winkelmann W. Preclinical Cushing’s syndrome in adrenal “Incidentalomas”: comparison with adrenal Cushing’s syndrome. J. Clin. Endocrinol. Metab. 75: 826, 1992.

    PubMed  CAS  Google Scholar 

  45. Caplan R.H., Strutt P.J., Wickus G.G. Subclinical hormone secretion by incidentally discovered adrenal masses. Arch. Surg. 129: 291, 1994.

    PubMed  CAS  Google Scholar 

  46. Fernandezreal J.M., Ricartengel W., Simo R. Pre-clinical Cushing’s syndrome: report of three cases and literature review. Horm. Res. 41: 5, 1994.

    Google Scholar 

  47. Ambrosi B., Peverelli S., Passini E., Re T., Ferrario R., Colombo P., Sartorio A., Faglia G. Abnormalities of endocrine function in patients with clinically “silent” adrenal mass. Eur. J. Endocrinol. 132: 422, 1995.

    PubMed  CAS  Google Scholar 

  48. Bencsik Z., Izabolks I., Goth M., Voros A., Kaszas I., Gonczi J., Kovacs L., Dohan O., Szilagyi G. Incidentally detected adrenal tumours (incidentalomas): histological heterogeneity and differentiated therapeutic approach. J. Intern. Med. 237: 585, 1995.

    PubMed  CAS  Google Scholar 

  49. Terzolo M., Osella G., Alì A., Borretta G., Magro G., Termine A., Paccotti P., Angeli A. Different patterns of steroid secretion in patients with adrenal incidentaloma. J. Clin. Endocrinol. Metab. 81: 740, 1996.

    PubMed  CAS  Google Scholar 

  50. Osella G., Terzolo M., Borretta G., Magro G., Alì A., Piovesan A., Paccotti P., Angeli A. Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas). J. Clin. Endocrinol. Metab. 79: 1532, 1994.

    PubMed  CAS  Google Scholar 

  51. Del Monte P., Bernasconi D., Bertolazzi L., Meozzi M., Badaracco B., Torre R., Marugo M. Increased 17-alfa-hydroxyprogesterone response to ACTH in silent adrenal adenoma: cause of effect? Clin. Endocrinol. (Oxf). 42: 273, 1995.

    Google Scholar 

  52. Bencsik Z., Szabolks I., Kovaks Z., Ferencz A., Voros A., Kaszas I., Bor K., Gonczi J., Goth M., Kovacs L., Dohan O., Szilagyi G. Low dehydroepiandrosterone sulfate (DHEAS-S) level is not a good predictor of hormonal activity in nonselected patients with incidentally detected adrenal tumours. J. Clin. Endocrinol. Metab. 81: 126, 1996.

    Google Scholar 

  53. Toth M., Racz K., Varga I., Szucs N., Szabò P., Futò L., Kiss R., Glaz E. Plasma dehydroepiandrosterone sulfate levels in patients with hyperfunctioning and non-hyperfunctioning adrenal tumours before and following adrenal surgery. The Endocrine Society, 10th Int. Congr. Endocrinol., San Francisco, USA, June 12–15, 1996, p. 3–618 (abs), 1996.

  54. Seppel T., Schlaghecke R. Augmented 17 a-hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21-hydroxylase activity in patients with incidentally discovered adrenal tumour (‘incidentalomas’). Clin. Endocrinol. (Oxf). 41: 455, 1994.

    Google Scholar 

  55. Ravichandran R., Lafferty F., Mcginniss M.J., Taylor H.C. Congenital adrenal hyperplasia presenting as massive adrenal incidentalomas in the sixth decade of life: report of two patients with 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 81: 1776, 1996.

    PubMed  CAS  Google Scholar 

  56. Jaresch S., Kornely E., Kley H.K., Schlaghecke R. Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 74: 685, 1992.

    PubMed  CAS  Google Scholar 

  57. Bauman A., Bauman C.G. Virilizing adrenocortical carcinoma. Development in a patient with salt-losing congenital adrenal hyperplasia. JAMA 248: 3140, 1982.

    PubMed  CAS  Google Scholar 

  58. Jaursch-Hancke C., Allolio B., Metzler U., Bidlingmaier F., Winkelmann W. Adrenocortical carcinoma in patients with untreated congenital adrenal hyperplasia (CAH). Acta Endocrinol. (Copenh.) (Oxf). 177(Suppl.): 146, 1988.

    Google Scholar 

  59. Turton D.B., O’Brian J.T., Shakir M.M. Incidental adrenal nodules: association with exaggerated 17-hydroxyprogesterone response to adrenocorticotropic hormone. J. Endocrinol. Invest. 15: 789, 1992.

    PubMed  CAS  Google Scholar 

  60. Aupetit-Faisant B., Blanchouin-Emeric N., Tenenbaum F., Battaglia C., Tabarin A., Amar J., Kuttenn F., Warnet A., Assayag B., Chamontin B., Touraine P.H., Lebrun P., Maunand B., Benoit A., Bletry O., Noel S., Lorcy Y., Allanic H., Legrand J.C. Plasma levels of aldosterone versus aldosterone precursors: a way to estimate the malignancy of asymptomatic and nonsecretory adrenal tumors: a French retrospective multicentric study. J. Clin. Endocrinol. Metab. 80: 2715, 1995.

    PubMed  CAS  Google Scholar 

  61. Suzuki H, Shibata H., Maruyama T., Ishimura Y., Saruta T. Significance of steroidogenic enzymes in the pathogenesis of hyperfunctioning and non-hyperfunctioning adrenal tumor. Steroids 60: 42, 1995.

    PubMed  CAS  Google Scholar 

  62. Siren J.E., Haapiainem R.K., Huikuri K.T., Sivula A. Incidentalomas of the adrenal gland: 36 operated patients and review of literature. World J. Surg. 17: 634, 1993.

    PubMed  CAS  Google Scholar 

  63. Seppel T., Becker A., Feldkamp J., Santen R., Schlaghecke R. Risk factors for adrenocortical malignancy in patients with incidentally discovered adrenal tumours. J. Endocrinol. 144(Suppl.), P43 (abs.), 1995.

    Google Scholar 

  64. Hensen J., Walters P., Stark S., Buhl M., Vecsei P., Shao X.J., Rico A.J., Dorr H.G., Oelkers W. Hypertension and plasma potassium in patients with “non-functioning” adrenocortical adenoma. The Endocrine Society, 77th Annual Meeting, Washington, June 1995, P3–45 (abs.), 1995.

  65. Furlani L., Deliera A., Alberiche M., Guerriero A., Muggeo M. Apparent 21-hydroxylase deficiency in incidentally discovered adrenal mass. J. Endocrinol. Invest. 19(Suppl. 5): 178 (abs.), 1996.

    Google Scholar 

  66. Racz K., Pinet F., Marton T., Szende B., Glaz E., Corvol P. Expression of steroidogenic enzyme messenger ribonucleic acids and corticosteroid production in aldosterone-producing and “nonfunctioning” adrenal adenomas. J. Clin. Endocrinol. Metab. 77: 677, 1993.

    PubMed  CAS  Google Scholar 

  67. Murakami C., Ishibashi M., Kondo M. Adrenal myelolipoma associated with congenital adrenal 21-hydroxylase deficiency. Int. Med. 31: 803, 1992.

    CAS  Google Scholar 

  68. Bevan J.S., Rees A. Dexamethasone-suppressible adrenal tumour in untreated 21-hydroxylase deficiency. Clin. Endocrinol. (Oxf). 44: 733, 1996.

    CAS  Google Scholar 

  69. Nagasaka S., Kubota K., Motegi T., Hayashi E., Ohta M., Takahashi T., Iwasaki Y., Koike M., Nishikawa T., Sasano H., Murakami T. A case of silent 21-hydroxylase deficiency with persistent adrenal insufficiency after removal of an adrenal incidentaloma. Clin. Endocrinol. (Oxf). 44: 111, 1996.

    CAS  Google Scholar 

  70. Reincke M. Steroid secretions in patients with adrenal incidentalomas. J. Clin. Endocrinol. Metab. 81: 3811, 1996.

    PubMed  CAS  Google Scholar 

  71. Passini E, Re T., Conti A., Sartorio A., Ambrosi B. Some aspects of preclinical Cushing’s syndrome of adrenal origin. J. Endocrinol. Invest. 19(Suppl. 5): 71 (abs.), 1996.

    Google Scholar 

  72. Tsagarakis S., Michaliou D., Vasilatou E., Nikolou H., Thalassinos N. Evidence for incomplete suppression of Cortisol on low-dose dexamethasone suppression test in patients with adrenal incidentalomas. Eur. J. Endocrinol. (Suppl. 2): 130 (abs.), 1994.

  73. Charbonnel B., Chatal J.F., Ozanne P. Does the corticoadrenal adenoma with “pre-Cushing’s” syndrome exist? J. Nucl. Med. 22: 1059, 1981.

    PubMed  CAS  Google Scholar 

  74. Beyer H.S., Doe R.P. Cortisol secretion by an incidentally discovered nonfunctional adrenal adenoma. J. Clin. Endocrinol. Metab. 62: 1317, 1986.

    PubMed  CAS  Google Scholar 

  75. Bogner U., Eggens U., Hensen J., Oelkers W. Incidentally discovered ACTH-dependent adrenal adenoma presenting as “Pre-Cushing’s syndrome”. Acta Endocrinol. 111: 89, 1986.

    PubMed  CAS  Google Scholar 

  76. Hensen J., Buhl M., Oelkers W. Diagnostisches und therapeutisches vorgehen bei patienten mit zufaellig entdeckten nebennierentumoren. In: Allolio B., Schulte H.M. (Eds.), Moderne Diagnostik und therapeutische Strategien bei Nebennierenerkrankungen. Schattauer Verlag, Stuttgart, New York, 1990, p. 210.

    Google Scholar 

  77. McLeod M., Thompson N., Gross M., Bondenson A., Bondenson L. Sub-clinical Cushing’s syndrome in patients with adrenal gland incidentalomas. Pitfalls in diagnosis and management. Am. Surg. 56: 398, 1990.

    PubMed  CAS  Google Scholar 

  78. Seppel T., Schlaghecke R. Subclinical hypercortisolism in incidentally detected adrenal adenoma. Deutch. Med. Wochen. 121: 503, 1996.

    CAS  Google Scholar 

  79. Kobayashi S., Seki T., Nonomura K., Gotoh T., Togashi M., Koyanagi T. Clinical experience of incidentally discovered adrenal tumor with particular reference to cortical function. J. Urol. 150: 8, 1993.

    PubMed  CAS  Google Scholar 

  80. Hensen J., Buhl M., Oelkers W. The functional spectrum of adrenocortical adenomas. Med. Hypoth. 40: 217, 1993.

    CAS  Google Scholar 

  81. Bernini G., Sgrò M., Molea N., Franchi F. A documented clinical case of pre-Cushing’s syndrome. The Endocrinologist 5: 377, 1995.

    Google Scholar 

  82. Tsuboi Y., Ishikawa S., Fujisawa G., Okada K., Saito T. Possible pre-Cushing’s syndrome due to an adrenal adenoma incidentally discovered. Endoer. J. 42: 509, 1995.

    CAS  Google Scholar 

  83. Laudat M.H., Billaud L., Thomopoulos P., Vera O., Yllia A., Luton J.P. Evening urinary free corticoids: a screening test in Cushing’s syndrome and incidentally discovered adrenal tumours. Acta Endocrinol. (Copenh) 199: 459, 1988.

    Google Scholar 

  84. Morio H., Terano T., Yamamoto K., Tomizuka T., Oeda T., Saito Y., Tamura Y., Sasano H. Serum levels of dehydroepiandrosterone sulfate in patients with asymptomatic Cortisol producing adrenal adenoma: comparison with adrenal Cushing’s syndrome and non-functional adrenal tumor. Endoer. J. 43: 387, 1996.

    CAS  Google Scholar 

  85. Ambrosi B., Sartorio A. Preclinical Cushing’s syndrome. Trends Endocrinol. Metab. 7: 113, 1996.

    PubMed  CAS  Google Scholar 

  86. Loli P., Vignati F., Da Re N., Milella M., Gelli D. Incidentally discovered “nonhypersecretory adrenal adenomas”: a scintigraphic and hormonal evaluation. The Endocrine Society, 77th Annual Meeting, Washington, June 1995, P3–44 (abs), 1995.

  87. Morioka M., Ohashi Y., Komatsu F., Sawada K., Ebara S., Ohashi T., Kondo K. Preclinical Cushing’s Syndrome: report of four cases and analysis of steroid contents in adenomas. Horm. Res. 46: 117, 1996.

    PubMed  CAS  Google Scholar 

  88. Tobinaga J., Imai T., Funahashi H., Tanaka Y., Wada M., Morita T., Yamada F., Tsukamura K., Oiwa M., Kikumori T., Sasano H., Takagi H. Incidentally discovered adrenocortical adenomas are not fully nonfunctioning: immunohistochemical and dispersed adrenocortical cell study. Endoer. J. 43: 79, 1996.

    CAS  Google Scholar 

  89. Huiras C.M., Pehling G.B., Caplan R.H. Adrenal insufficiency after operative removal of apparently nonfunctioning adrenal adenomas. JAMA 261: 894, 1989.

    PubMed  CAS  Google Scholar 

  90. Virkkala A., Valimaki M., Pelkonen R., Huikuri K., Kahri A., Kivisaari L., Korhonen T., Salmi J., Seppala P. Endocrine abnormalities in patients with adrenal tumours incidentally discovered on computed tomography. Acta Endocrinol. (Copenh.) 121: 67, 1989.

    CAS  Google Scholar 

  91. Rosen H.N., Swartz S.L. Subtle glucocorticoid excess in patients with adrenal incidentaloma. Am. J. Med. 92: 213, 1992.

    PubMed  CAS  Google Scholar 

  92. Sutton M.G., Sheps S.G., Lie J.T. Prevalence of clinically unsuspected phaeochromocytoma: a review of a 50-year autopsy series. Mayo Clin. Proc. 56: 354, 1981.

    PubMed  CAS  Google Scholar 

  93. Krane N.K. Clinically unsuspected pheochromocytomas: experience at Henry Ford Hospital and a review of the literature. Ann. Intern. Med. 146: 54, 1986.

    CAS  Google Scholar 

  94. Yamakita N., Saitoh M., Mercado-Asis L.B. Asymptomatic adrenal tumor: 386 cases in Japan including seven of our own. Endocrinol. Jpn. 37: 671, 1990.

    PubMed  CAS  Google Scholar 

  95. Mannelli M., Pupilli C., Lanzillotti R., Lanni L., Amorosi A., Credi G., Pratesi G. A nonsecreting pheochromocytoma presenting as an incidental adrenal mass. Report on a case. J. Endocrinol. Invest. 16: 817, 1993.

    PubMed  CAS  Google Scholar 

  96. Sone H., Okuda Y., Nakamura Y., Ishikawa N., Yamaoka T., Kawakami Y., Odawara M., Matsushima T., Kaway K., Yamashita K. Radioiodinated metaiodobenzylguanidine scintigraphy for pheochromocytoma — a false-positive case of adrenocortical adenoma and literature review. Horm. Res. 46: 138, 1996.

    PubMed  CAS  Google Scholar 

  97. Reincke M., Peter M., Karl M. Does 21-hydroxylase deficiency play a role in the pathogenesis of non-functional adrenal adenomas? Exp. Clin. Endocrinol. (Suppl. 1) 102: 74, 1994.

    Google Scholar 

  98. Burgess J.R., Harle R.A., Tucker P., Parameswaran V., Davies P., Greenway T.M., Shepherd J.J. Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1. Arch. Surg. 131: 699, 1996.

    PubMed  CAS  Google Scholar 

  99. Terzolo M., Boccuzzi A., Alì A., Osella G., Luceri S., Matrella C., Arcuno L., Borriero M., Rovero E., Angeli A. 24-hour profile of blood pressure in patients with adrenal incidentaloma. Comparison with adrenal Cushing’s Syndrome. The Endocrine Society, 10th Intern. Congr. Endocrinol., San Francisco, USA, June 12–15, 1996, P3–596 (abs), 1996.

  100. Sartorio A., Conti A., Ferrario S., Passini E., Re T., Ambrosi B. Serum bone Gla protein (BGP) and carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in patients with Cushing’s syndrome before and after surgery. Postgrad. Med. J. 72: 419, 1996.

    PubMed Central  PubMed  CAS  Google Scholar 

  101. Osella G., Terzolo M., Piovesan A., Alì A., Termine A., Reimondo G., Paccotti P., Angeli A. Markers of bone and collagen turnover in patients with adrenal incidentaloma. The Endocrine Society, 10th Intern. Congr. Endocrinol., San Francisco, USA, June 12–15, 1996, P3–623 (abs), 1996.

  102. Sartorio A., Ambrosi B., Colombo P., Morabito F., Faglia G. Osteocalcin levels in Cushing’s disease before and after treatment. Horm. Metab. Res. 20: 70, 1988.

    PubMed  CAS  Google Scholar 

  103. Piovesan A., Terzolo M., Reimondo G., Pia A., Codegone A., Osella G., Boccuzzi A., Paccotti P., Angeli A. Biochemical markers of bone and collagen turnover in acromegaly or Cushing’s syndrome. Horm. Metab. Res. 26: 234, 1994.

    PubMed  CAS  Google Scholar 

  104. Mold J.W., Stein H.F. The cascade effect in the clinical care of patients. N. Engl. J. Med. 314: 512, 1986.

    PubMed  CAS  Google Scholar 

  105. Abecassis M., McLoughlin M.J., Langer B., Kudlow J.E. Serendipitous adrenal masses: prevalence, significance and management. Am. J. Surg. 149: 783, 1985.

    PubMed  CAS  Google Scholar 

  106. Glazer H.S., Weyman P.J., Sagel S.S., Levitt R.G., McClennan B.L. Nonfunctioning adrenal masses: incidental discovery on computed tomography. Am. J. Roentgenol. 139: 89, 1982.

    Google Scholar 

  107. Prinz R.A., Brooks M.H., Churchill R., Graner J.L., Lawrence A.M., Paloyan E., Sparagana M. Incidental asymptomatic adrenal masses detected by computed tomographic scanning. JAMA 248: 701, 1982.

    PubMed  CAS  Google Scholar 

  108. Thompson N.W., Cheung P.S.Y. Diagnosis and treatment of functioning and nonfunctioning adrenocortical neoplasm including incidentalomas. Surg. Clin. North Am. 67: 423, 1987.

    PubMed  CAS  Google Scholar 

  109. Gross M.D., Shapiro B., Bouffard J.A. et al. Distinguishing benign from malignant euadrenal masses. Ann. Intern. Med. 109: 613, 1988.

    PubMed  CAS  Google Scholar 

  110. Weisnagel S.J., Gagner M., Breton G., Pomp A., Pharand D., Lacroix A. Laparoscopic adrenalectomy. The Endocrinologist 6: 169, 1996.

    Google Scholar 

  111. Griffing G.T. Editorial: A-I-D-S: the new endocrine epidemic. J. Clin. Endocrinol. Metab. 79: 1530, 1994.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ambrosi, B., Passini, E., Re, T. et al. The clinical evaluation of silent adrenal masses. J Endocrinol Invest 20, 90–107 (1997). https://doi.org/10.1007/BF03347983

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347983

Key-words

Navigation